Announced Wed, 2 Sept, 2026 · 23:12 IST

All 6 resolutions passed at 43rd AGM of Kwality Pharmaceuticals

Board & Shareholder Meetings View source PDFExplain this filing

KPL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.9%1-day move
₹3397.60
prior close
₹3428.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.3-1.3-1.3-3.2-2.9+0.6+8.2+5.1+3.6+0.1+8.0+7.0——
Up moveDown movePending
AI summary

Kwality Pharmaceuticals held its 43rd AGM on August 31, 2026 via video conferencing. All 6 resolutions were passed with requisite majority: adoption of FY26 audited standalone and consolidated financial statements, reappointment of directors Aditya Arora and Anju Arora, appointment of Swanith Kapoor as Independent Director, reappointment of Aditya Arora as Whole Time Director with remuneration, and ratification of cost auditors remuneration. About 45 percent of outstanding shares voted, with over 99.96 percent approval on each resolution.

Likely market impact

Routine AGM outcome with near-unanimous shareholder support. Board and management continuity confirmed, no material surprise expected for the stock.